Thoratec Presentation at Canaccord Adams Conference to be Webcast
November 09 2009 - 7:35PM
PR Newswire (US)
PLEASANTON, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Thoratec
Corporation (NASDAQ:THOR), a world leader in device-based
mechanical circulatory support therapies to save, support and
restore failing hearts, said today that it will be participating in
the Third Annual Canaccord Cardiovascular Conference on Tuesday,
November 10. The presentation by Gary F. Burbach, president and
chief executive officer, will begin at 8 a.m., Pacific Standard
Time (11 a.m., Eastern Standard Time). The presentation will be
available through the conference website at
http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2843940 and
via the company's website at http://www.thoratec.com/ Thoratec is a
world leader in therapies to address advanced-stage heart failure.
The company's product lines include the Thoratec® VAD (Ventricular
Assist Device) and HeartMate® LVAS (Left Ventricular Assist
System), with more than 14,000 devices implanted in patients
suffering from heart failure. Additionally, its International
Technidyne Corporation (ITC) Division is a leader in point-of-care
blood testing and skin incision products. Thoratec is headquartered
in Pleasanton, California. For more information, visit the
company's websites at http://www.thoratec.com/ or
http://www.itcmed.com/. DATASOURCE: Thoratec Corporation CONTACT:
David Smith, Executive Vice President, Chief Financial Officer of
Thoratec Corporation, +1-925-847-8600, or, Neal B. Rosen of
Ruder-Finn, +1-415-692-3058, for Thoratec Web Site:
http://www.thoratec.com/
Copyright